| Entry |
|
|---|
| Name |
Ulotaront (USAN/INN) |
|---|
| Formula |
C9H13NOS
|
|---|
| Exact mass |
183.0718
|
|---|
| Mol weight |
183.27
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Efficacy |
Neuroleptic, Trace amine associated receptor agonist |
|---|
| Comment |
Treatment of schizophrenia, narcolepsy, Parkinson's disease psychosis and major depressive disorder
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Serotonin
HTR1A
D12474 Ulotaront (USAN/INN)
Trace amine
TAAR1
D12474 Ulotaront (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 12
1 C1x C 10.2900 -16.8000
2 C1x C 10.2900 -18.2000
3 C8y C 11.5024 -18.9000
4 C8y C 12.7149 -18.2000
5 C1y C 12.7149 -16.8000
6 O2x O 11.5024 -16.1000
7 C1b C 13.9460 -16.0890
8 N1b N 15.1512 -16.7847
9 C1a C 16.3335 -16.1019
10 C8x C 11.7935 -20.2694
11 C8x C 13.1859 -20.4158
12 S2x S 13.7553 -19.1368
BOND 13
1 1 2 1
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 1
6 1 6 1
7 5 7 1 #Up
8 7 8 1
9 8 9 1
10 3 10 1
11 10 11 2
12 11 12 1
13 4 12 1
|
|---|
